Harnessing HIV for therapy, basic research and biotechnology.

[1]  E. Wolf,et al.  Generation of Transgenic Cattle by Lentiviral Gene Transfer into Oocytes1 , 2004, Biology of reproduction.

[2]  P. Sharp,et al.  Cre-lox-regulated conditional RNA interference from transgenes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Mallet,et al.  A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. , 2004, Human gene therapy.

[4]  Boro Dropulic,et al.  Antisense-Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance , 2004, Journal of Virology.

[5]  P. Carmeliet,et al.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model , 2004, Nature.

[6]  A. Annoni,et al.  Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. , 2004, Blood.

[7]  I. Verma,et al.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Cortese,et al.  Gene therapy progress and prospects: transcription regulatory systems , 2004, Gene Therapy.

[9]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[10]  G. Hannon,et al.  Inducible, reversible, and stable RNA interference in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Déglon,et al.  Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. , 2003, Human molecular genetics.

[12]  E. Wolf,et al.  Efficient transgenesis in farm animals by lentiviral vectors , 2003, EMBO reports.

[13]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[14]  M. Wiznerowicz,et al.  Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference , 2003, Journal of Virology.

[15]  V. Kiermer,et al.  Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  Peter A. Jones,et al.  Establishment of conditional vectors for hairpin siRNA knockdowns. , 2003, Nucleic acids research.

[17]  D. Pardoll,et al.  Immunotherapy of established tumors using bone marrow transplantation with antigen gene–modified hematopoietic stem cells , 2003, Nature Medicine.

[18]  F. Holstege,et al.  Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vector , 2003, EMBO reports.

[19]  E. Tekle,et al.  Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Michael T. McManus,et al.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.

[21]  N. Déglon,et al.  Lentiviral-mediated RNA interference. , 2002, Human gene therapy.

[22]  L. Naldini,et al.  Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons , 2002, Gene Therapy.

[23]  R. Hammer,et al.  Production of transgenic rats by lentiviral transduction of male germ-line stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Martins,et al.  In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins , 2002, Journal of Virology.

[25]  L. Naldini,et al.  Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. , 2002, Blood.

[26]  P. Morel,et al.  Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Christopher A. Ross,et al.  Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length , 2002, The Journal of Neuroscience.

[29]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[30]  M. Kay,et al.  Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. , 2002, Human gene therapy.

[31]  H. Bujard,et al.  Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  I. Verma,et al.  Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[34]  R. Nagel,et al.  Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy , 2001, Science.

[35]  F. Moreau-Gaudry,et al.  High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. , 2001, Blood.

[36]  A. Kingsman,et al.  Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. , 2001, Human molecular genetics.

[37]  S. Eisele,et al.  Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[39]  I. Verma,et al.  Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  K. Ozawa,et al.  Gene Transfer into Nonhuman Primate Hematopoietic Stem Cells: Implications for Gene Therapy , 2001, Stem cells.

[41]  S. Karlsson,et al.  Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. , 2000, Blood.

[42]  J. Bloch,et al.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.

[43]  R. Jaenisch,et al.  Retroviral Expression in Embryonic Stem Cells and Hematopoietic Stem Cells , 2000, Molecular and Cellular Biology.

[44]  J. Kappes,et al.  Lentiviral Vector Transduction of Hematopoietic Stem Cells that Mediate Long‐Term Reconstitution of Lethally Irradiated Mice , 2000, Stem cells.

[45]  Michel Sadelain,et al.  Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin , 2000, Nature.

[46]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  F. Gage,et al.  Lentiviral vectors: regulated gene expression. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  M. Halterman,et al.  Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements , 1999, Journal of Virology.

[49]  B. Torbett,et al.  Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. , 1999, Science.

[50]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[51]  J. Olsen.  Gene transfer vectors derived from equine infectious anemia virus , 1998, Gene Therapy.

[52]  E. Poeschla,et al.  Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors , 1998, Nature Medicine.

[53]  D. Peterson,et al.  Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors , 1997, Nature Genetics.

[54]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[55]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[56]  U. Deuschle,et al.  Tetracycline-reversible silencing of eukaryotic promoters , 1995, Molecular and cellular biology.

[57]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[58]  F. Bushman,et al.  Integration site selection by lentiviruses: biology and possible control. , 2002, Current topics in microbiology and immunology.

[59]  M. Kay,et al.  Efficient lentiviral transduction of liver requires cell cycling in vivo , 2000, Nature Genetics.

[60]  ARTICLE doi:10.1016/S1525-0016(03)00169-2 The Effect of Age on Hepatic Gene Transfer with Self-Inactivating Lentiviral Vectors in Vivo , 2022 .